ABSI AbSci Corp

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

$10.10  -0.46 (-4.36%)
As of 12/03/2021 11:41:26 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/22/2021
Outstanding shares:  92,591,472
Average volume:  218,291
Market cap:   $971,284,541
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00091E109
ISIN:        US00091E1091
Sedol:      BN94K69
Valuation   (See tab for details)
PE ratio:   -12.52
PB ratio:   2.52
PS ratio:   160.33
Return on equity:   -20.81%
Net income %:   -1,332.67%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy